10-K

Company

Oaktree Acquisition Corp. III Life Sciences

Filed

March 27, 2025

Period of Report

December 31, 2024

Accession Number

0001193125-25-065546

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →